SCHEMBL8898228

SCHEMBL8898228

C[C](Cc1cccc2ccccc12)C1=NCCO1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.43
▸ MAPT P10636 3/20 0.43
▸ PKM P14618 1/20 0.43
▸ CYP2D6 P10635 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ TAAR1 Q96RJ0 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ OPRM1 P35372 1/20 0.40
▸ NISCH Q9Y2I1 1/20 0.40
▸ SIRT5 Q9NXA8 1/20 0.39
▸ ATM Q13315 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28883377 0.76 SSTR4 (0.41) TDP1MAPTPKMCYP2D6CYP1A2
SCHEMBL29207386 0.72 ADRA2A (0.51) MAPTCYP2D6CYP1A2CYP2C19MAPK1
SCHEMBL5008796 0.71 TDP1 (0.59) TDP1CYP2D6CYP1A2CYP2C19LMNA
SCHEMBL7617976 0.71 TDP1 (0.55) TDP1CYP2D6CYP1A2CYP2C19LMNA
SCHEMBL1692324 0.70 MTNR1A (0.36) MAPTCYP2D6CYP1A2MAPK1LMNA
SCHEMBL28688898 0.70 CDC25B (0.49) TDP1MAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL269372 0.69 TDP1 (0.62) TDP1CYP2D6CYP1A2CYP2C19SIRT5
SCHEMBL5831206 0.67 CYP2C19 (0.59) TDP1CYP2D6CYP1A2CYP2C19LMNA
SCHEMBL6027916 0.67 TDP1 (0.58) TDP1MAPTCYP2D6CYP1A2CYP2C19
SCHEMBL266575 0.67 TDP1 (0.69) TDP1CYP2D6CYP1A2CYP2C19SIRT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607334-B1 CYCLIC UREAS AND ANALOGUES USEFUL AS RETROVIRAL PROTEASE INHIBITIORS DU PONT MERCK PHARMA (US) 1997-07-30 — — EP claimed
Send feedback